Federico Longo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Lymph Node Metastasis

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Rivera, Federico Longo, Marta Martín Richard, Paula Richart, Maria Alsina, Alberto Carmona-Bayonas, Ana Belén Custodio, Ana Fernández Montes, Javier Gallego, Tania C Fleitas
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Gregorio Garrido-Cantero, Federico Longo, Javier Hernández-González, Ángel Pueyo, Tomás Fernández-Aparicio, Juan F Dorado, Javier C Angulo, null On Behalf Of The Madrid Cancer Registry Rtmad Investigators
Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021). Cancers 15 (6) (2023)
Gregorio Garrido-Cantero, Federico Longo, Javier Hernández-González, Ángel Pueyo, Tomás Fernández-Aparicio, Juan F Dorado, Javier C Angulo, null On Behalf Of The Madrid Cancer Registry Rtmad Investigators
Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021). Cancers 15 (6) (2023)
Victor Duque-Santana, Fernando López-Campos, Margarita Martin, Lira Pelari, Antonio Hernandez, Mireia Valero, Julio Galindo Álvarez, Pablo Priego Jiménez, Marta Cuadrado Ayuso, Federico Longo, María Caminoa-Lizarralde, Sonsoles Sancho
Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 27 (3) (2022)
Ivan Marquez-Rodas, Federico Longo, Maria E Rodríguez-Ruiz, Antonio Calles, Santiago Ponce-Aix, Maria Jove, Belén Rubio-Viqueira, Jose Luis Perez-Gracia, Ana Gómez-Rueda, Miguel Martín, Mariano Ponz-Sarvisé, Rosa Álvarez, Ainara Soria-Rivas, Enrique de Miguel, Rocío Ramos-Medina, Eduardo Castañon, Pablo Gajate, Cayetano Sempere Ortega, Elisabeth Jiménez-Aguilar, Maria Angela Aznar, Aitana Calvo, Pedro P López-Casas, Salvador Martín-Algarra, Miguel Martín, Dominique Tersago, Marisol Quintero, Ignacio Melero
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. Science translational medicine 12 (565) (2021)